| Angiogenesis-related pathways in the pathogenesis of ovarian cancer NG Gavalas, M Liontos, SP Trachana, T Bagratuni, C Arapinis, C Liacos, ... International journal of molecular sciences 14 (8), 15885-15909, 2013 | 176 | 2013 |
| Age‐dependent and gender‐dependent antibody responses against SARS‐CoV‐2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine E Terpos, IP Trougakos, F Apostolakou, I Charitaki, AD Sklirou, ... American journal of hematology 96 (7), E257, 2021 | 167 | 2021 |
| Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 … IP Trougakos, E Terpos, C Zirou, AD Sklirou, F Apostolakou, S Gumeni, ... BMC medicine 19, 1-11, 2021 | 61 | 2021 |
| Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies T Bagratuni, I Ntanasis-Stathopoulos, M Gavriatopoulou, ... Leukemia 32 (12), 2617-2625, 2018 | 46 | 2018 |
| Toll-like receptor 4 activation promotes multiple myeloma cell growth and survival via suppression of the endoplasmic reticulum stress factor chop T Bagratuni, AD Sklirou, E Kastritis, CI Liacos, C Spilioti, ... Scientific reports 9 (1), 3245, 2019 | 33 | 2019 |
| Prevalence of autoantibodies against contractile proteins in coronary artery disease and their clinical implications. G Dangas, MM Konstadoulakis, SE Epstein, CI Stefanadis, GD Kymionis, ... The American journal of cardiology 85 (7), 870-2, A6, A9, 2000 | 33 | 2000 |
| Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced … CS Boskos, C Liacos, D Korkolis, K Aygerinos, I Lamproglou, E Terpos, ... Journal of surgical oncology 102 (5), 408-412, 2010 | 28 | 2010 |
| Apoptosis in cells of bronchoalveolar lavage: a cellular reaction in patients who die with sepsis and respiratory failure C Liacos, S Katsaragakis, MM Konstadoulakis, EG Messaris, ... Critical care medicine 29 (12), 2310-2317, 2001 | 27 | 2001 |
| Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study A Cowan, F Ferrari, SS Freeman, R Redd, H El-Khoury, J Perry, V Patel, ... The Lancet Haematology 10 (3), e203-e212, 2023 | 25 | 2023 |
| Whole-genome sequence analysis of an extensively drug-resistant Salmonella enterica serovar Agona isolate from an Australian silver gull (Chroicocephalus novaehollandiae … ML Cummins, M Sanderson-Smith, P Newton, N Carlile, DN Phalen, ... Msphere 5 (6), 10.1128/msphere. 00743-20, 2020 | 23 | 2020 |
| TLR4/TIRAP polymorphisms are associated with progression and survival of patients with symptomatic myeloma T Bagratuni, E Terpos, E Eleutherakis‐Papaiakovou, D Kalapanida, ... British journal of haematology 172 (1), 44-47, 2016 | 17 | 2016 |
| A molecular signature of circulating MicroRNA can predict osteolytic bone disease in multiple myeloma AM Papanota, P Tsiakanikas, CK Kontos, P Malandrakis, CI Liacos, ... Cancers 13 (15), 3877, 2021 | 16 | 2021 |
| Characterization of a PERK kinase inhibitor with anti-myeloma activity T Bagratuni, D Patseas, N Mavrianou-Koutsoukou, CI Liacos, AD Sklirou, ... Cancers 12 (10), 2864, 2020 | 16 | 2020 |
| miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome MA Papadimitriou, AM Papanota, PG Adamopoulos, KM Pilala, CI Liacos, ... British journal of cancer 126 (1), 79-90, 2022 | 15 | 2022 |
| A cancer-related microRNA signature shows biomarker utility in multiple myeloma AM Papanota, P Karousi, CK Kontos, PI Artemaki, CI Liacos, ... International Journal of Molecular Sciences 22 (23), 13144, 2021 | 15 | 2021 |
| Cell-free DNA analysis for the detection of MYD88 and CXCR4 mutations in IgM monoclonal gammopathies; an update with clinicopathological correlations I Ntanasis-Stathopoulos, T Bagratuni, M Gavriatopoulou, D Patseas, ... American journal of hematology 95 (6), E148-E150, 2020 | 12 | 2020 |
| Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies T Bagratuni, A Markou, D Patseas, N Mavrianou-Koutsoukou, F Aktypi, ... Blood advances 6 (1), 189-199, 2022 | 10 | 2022 |
| tRNA derivatives in multiple myeloma: investigation of the potential value of a tRNA-derived molecular signature P Karousi, AM Papanota, PI Artemaki, CI Liacos, D Patseas, ... Biomedicines 9 (12), 1811, 2021 | 9 | 2021 |
| Aberrant plasma cell contamination of peripheral blood stem cell autografts, assessed by next-generation flow cytometry, is a negative predictor for deep response post … IV Kostopoulos, E Eleutherakis-Papaiakovou, P Rousakis, ... Cancers 13 (16), 4047, 2021 | 9 | 2021 |
| Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy M Moscvin, CI Liacos, T Chen, F Theodorakakou, D Fotiou, S Hossain, ... Blood Cancer Journal 13 (1), 31, 2023 | 7 | 2023 |
